The Alexion Pharmaceutical SEC FCPA enforcement action represents another in the long line of enforcement actions against drug and device companies.  The drug and device industries have been – and will continue to be — easy marks for prosecutors to investigate and prosecute for foreign bribery.  There are a number of reason for this. First, global drug and device depend on interactions with foreign healthcare...